首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   221904篇
  免费   5369篇
  国内免费   2392篇
耳鼻咽喉   1579篇
儿科学   7255篇
妇产科学   4041篇
基础医学   21797篇
口腔科学   2947篇
临床医学   17927篇
内科学   38498篇
皮肤病学   1195篇
神经病学   19359篇
特种医学   10356篇
外国民族医学   13篇
外科学   33824篇
综合类   9260篇
现状与发展   5篇
一般理论   15篇
预防医学   21276篇
眼科学   3853篇
药学   13875篇
  27篇
中国医学   2646篇
肿瘤学   19917篇
  2023年   522篇
  2022年   785篇
  2021年   1556篇
  2020年   1285篇
  2019年   1287篇
  2018年   23211篇
  2017年   18559篇
  2016年   20649篇
  2015年   2711篇
  2014年   2973篇
  2013年   3107篇
  2012年   10044篇
  2011年   24337篇
  2010年   21076篇
  2009年   13482篇
  2008年   21848篇
  2007年   24272篇
  2006年   3025篇
  2005年   4459篇
  2004年   5459篇
  2003年   6565篇
  2002年   4441篇
  2001年   1938篇
  2000年   1725篇
  1999年   1362篇
  1998年   833篇
  1997年   844篇
  1996年   543篇
  1995年   506篇
  1994年   469篇
  1993年   338篇
  1992年   452篇
  1991年   462篇
  1990年   450篇
  1989年   370篇
  1988年   376篇
  1987年   311篇
  1986年   263篇
  1985年   257篇
  1984年   166篇
  1983年   167篇
  1982年   116篇
  1980年   114篇
  1979年   130篇
  1978年   99篇
  1977年   84篇
  1975年   109篇
  1974年   104篇
  1970年   77篇
  1969年   80篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
目的 以学生需求调查分析为基础,探索普通本科医学院校预防医学专业毕业实习考核模式。方法 采用分层整群抽样方法抽取昆明医科大学2012 级~ 2014 级的五年制本科预防医学专业310 名学生为研究对象,采用问卷和访谈提纲进行调查,内容主要包括对预防医学专业毕业实习考核内容、考核方式、考核主体等的认识、看法及评价。结果 92.81% 的学生认为需要由职业素养、综合知识、专业能力构成毕业实习考核内容,不同年级的学生对考核内容需求评价差异有统计学意义(P < 0.05);76.80% 的学生认为毕业实习考核方式可采用组合方式。访谈结果揭示,预防医学专业学生认同并愿接受内容更丰富、方式多样的毕业实习考核。结论 以多元化为导向构建预防医学专业的毕业实习考核模式,较适应预防医学人才培养的需要。  相似文献   
22.
23.
Graefe's Archive for Clinical and Experimental Ophthalmology - Intravitreal injection of the VEGF-binding protein aflibercept is widely used to treat various ocular diseases. In vitro,...  相似文献   
24.
MicroRNAs (miRNAs) have been found to be aberrantly expressed and exert essential roles in the tumorigenesis and progression of gastric cancer (GC). miR-301b-3p has been recognized as a cancer-related miRNA in lung cancer, bladder cancer and hepatocellular carcinoma. However, the function of miR-301b-3p in GC progression and its underlying mechanism have not been studied yet. In this study, we found that miR-301b-3p expression was up-regulated in GC tissues compared to adjacent noncancerous tissues. Furthermore, the elevated levels of miR-301b-3p were detected in GC cell lines (SGC-7901, AGS, MKN-45 and MGC-803) as compared with GES-1 cells. Interestingly, GC tissues from patients with tumor size ≥ 5 cm and advanced tumor stages showed obvious higher levels of miR-301b-3p compared to matched controls. Functionally, miR-301b-3p knockdown prominently inhibited cell proliferation, and induced cell cycle arrest at G1 phase and apoptosis in MGC-803 cells. Meanwhile, ectopic expression of miR-301b-3p conversely regulated these biological behaviors of MKN-45 cells. Next, we found that miR-301b-3p knockdown increased, whereas miR-301b-3p overexpression reduced the expression of zinc finger and BTB domain containing 4 (ZBTB4) in GC cells. Accordingly, luciferase reporter assay identified ZBTB4 as a direct target of miR-301b-3p. ZBTB4 overexpression markedly restrained the growth of MGC-803 cells. More importantly, ZBTB4 silencing partially reversed miR-301b-3p knockdown-induced tumor suppressive effects on MGC-803 cells. In conclusion, we firstly revealed that miR-301-3p was highly expressed in GC and contributed to tumor progression via attenuating ZBTB4, which might provide a novel molecular-targeted strategy for GC treatment.  相似文献   
25.
26.
Despite a dramatic decrease in vertical transmission of HIV in the developed world, maternal HIV infection acquired after negative prenatal screening still leaves a window of vulnerability. Through quality assurance programs in two Canadian Provinces, five cases where perinatal HIV transmission occurred despite negative prenatal screening were identified between 2005 and 2015. Maternal risk factors such as intravenous drug use, high–risk sexual behavior, hepatitis C virus co–infection, and belonging to high prevalence minority groups were common. Two mothers had their negative HIV test performed in the first trimester and three mothers had negative testing in the third trimester. All babies were clinically healthy at delivery with a normal weight. Three babies were tested following subsequent identification of maternal HIV infection and two babies presented with opportunistic infections leading to their diagnoses. The characteristics of these cases suggest that to achieve complete elimination of vertical HIV transmission, selective and innovative clinical management of mothers at high risk for HIV may be required.  相似文献   
27.
28.
目的:以HPLC法同时测定保健食品中非法添加的阿替洛尔、盐酸可乐定、氢氯噻嗪、盐酸哌唑嗪、卡托普利、利血平、硝苯地平、氨氯地平、尼群地平、尼莫地平、非洛地平和尼索地平。方法:HPLC法,采用Agilent Extend C18(4.6 mm × 250 mm,5 μm)色谱柱,以乙腈-0.2%磷酸溶液为流动相,梯度洗脱;流速:1.0 mL·min-1;柱温:35 ℃;检测波长:220 nm。结果:上述12个成分在各自线性范围内均线性良好,r均>0.996 9。平均回收率为94.8%~103.1%,RSD为0.89% ~ 1.7% (n=9)。结论:此法简便、准确、重复性好,可同时测定降压类保健食品中非法添加的12种化学成分。  相似文献   
29.

Background

A quadrivalent human papillomavirus (qHPV) vaccine (HPV6/11/16/18) has demonstrated efficacy and acceptable safety in international studies. However, these studies did not include participants from mainland China, which has a substantial burden of HPV-related disease. This is the first safety report with a follow-up period of up to 90?months from a randomized, double-blind, placebo-controlled trial of qHPV vaccine in Chinese women 20–45?years of age.

Methods

Participants were randomized 1:1 to receive three doses of qHPV vaccine or placebo (Day 1, Month 2, and Month 6). Efficacy outcomes are reported elsewhere. Injection-site and systemic adverse events (AEs) were collected using vaccination report cards (VRCs) for 15?days following each vaccination. Serious AEs (SAEs), pregnancy outcomes, new medical conditions, and fetal/infant SAEs were collected during the entire study.

Results

Of 3006 participants randomized, AEs were reported by 926 (61.8%) qHPV vaccine recipients and 856 (57.1%) placebo recipients over the entire study. Four participants (two in each group) discontinued the study vaccination due to AEs that were considered vaccination-related. Within 15?days following any vaccination, injection-site AEs prompted for on the VRC were more frequent among qHPV vaccine recipients (37.6% vs 27.8%), and systemic AEs prompted for on the VRC were similar in frequency between qHPV vaccine and placebo groups (46.8% vs 45.1%). Thirty-eight and 43 participants reported SAEs in qHPV vaccine and placebo groups, respectively. No SAE was considered qHPV vaccine-related. Pregnancy outcomes, fetal/infant SAEs, and new medical conditions were generally similar in frequency between the qHPV vaccine and placebo groups, and within normal ranges.

Conclusion

The qHPV vaccine was well tolerated and demonstrated a favorable safety profile in Chinese women 20–45?years of age, consistent with findings from global trials and safety surveillance studies.Trial registration: clinicaltrials.gov; NCT00834106.  相似文献   
30.
杨建  王敏  高莹  王舒 《天津中医药》2020,37(3):313-317
[目的]明确自发性高血压大鼠(SHR)脑损害与RhoA、ROCK-1的相关性,探讨针刺干预SHR脑保护的Rho通路机制。[方法]将SHR随机分为模型对照组、太冲穴组,WKY大鼠设为正常对照组。太冲穴组针刺干预4周,其余两组在干预期内给予相同程度、相同时长的抓取。观测各组大鼠收缩压、舒张压、平均动脉压的改变;苏木精-伊红(HE)染色观察脑组织形态学改变;蛋白免疫印迹(Western blot)法测定各组大鼠脑组织中RhoA、ROCK-1的表达水平。[结果]在干预周期内,正常对照组收缩压、舒张压、平均压均处于正常血压范围内。与正常对照组比较,模型对照组收缩压、舒张压、平均压均较高,且有随着周龄增加而增高的趋势。与模型对照组相比,太冲穴组可有效降低收缩压,有降低舒张压、平均压的趋势。模型对照组较正常对照组脑组织细胞排列紊乱,细胞坏死及间质水肿程度加重,RhoA、ROCK-1表达升高;太冲穴组与模型对照组比较,脑细胞排列规则,细胞坏死及间质水肿消失,RhoA、ROCK-1表达下降。[结论]针刺太冲穴能有效降低SHR血压,改善脑损害,其机制可能与抑制RhoA/ROCK-1信号通路表达相关。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号